* Oncology Institute Inc TOI.OQ TOI.O is expected
to report
results on November 9.
* The Cerritos California-based company is expected to
report
revenue of $68.95 million, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Oncology Institute
Inc is
for a loss of 18 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is also "Strong Buy".
* Wall Street's median 12-month price target for Oncology
Institute Inc is $8.5, above its last closing price of $3.28.
This summary was machine generated November 8 at 03:09 GMT. All
figures in US dollars unless otherwise stated